CIRCULATING TUMOR DNA
Clinical trials for CIRCULATING TUMOR DNA explained in plain language.
Never miss a new study
Get alerted when new CIRCULATING TUMOR DNA trials appear
Sign up with your email to follow new studies for CIRCULATING TUMOR DNA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail aims to eradicate hidden breast cancer cells
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and atezolizumab, can clear leftover cancer cells in the breast or lymph nodes of people with triple negative breast cancer. About 40 participants who still have cancer after standard chemotherapy will receive th…
Matched conditions: CIRCULATING TUMOR DNA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blood test could spot lung cancer return risk after surgery
Disease control Recruiting nowThis study looks at whether a simple blood test that finds cancer DNA can help doctors decide who needs extra treatment after lung cancer surgery. About 66 people who had their lung cancer removed will either get chemo-immunotherapy or just be watched. The goal is to see if the b…
Matched conditions: CIRCULATING TUMOR DNA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Blood test may spare some colon cancer patients from chemo
Knowledge-focused Recruiting nowThis study looks at whether a blood test that detects tiny bits of tumor DNA after surgery can help decide which stage II colon cancer patients should get chemotherapy. About 1,320 patients will be randomly assigned to either have their test results used to guide treatment or to …
Matched conditions: CIRCULATING TUMOR DNA
Phase: NA • Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Blood test and patient surveys aim to outsmart vulva cancer recurrence
Knowledge-focused Recruiting nowThis study is testing whether regular patient surveys and a special blood test (circulating tumor DNA) can spot vulva cancer returning earlier than standard check-ups. About 295 women with vulva cancer will fill out symptom surveys every four months and give blood samples for two…
Matched conditions: CIRCULATING TUMOR DNA
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Blood test may guide ovarian cancer maintenance therapy
Knowledge-focused Recruiting nowThis study is testing whether a blood test for circulating tumor DNA (ctDNA) can help predict how well PARP inhibitor maintenance therapy works in women with high-grade serous ovarian cancer. Researchers will collect blood samples before surgery, after chemotherapy, during target…
Matched conditions: CIRCULATING TUMOR DNA
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a breath test spot lung cancer return?
Knowledge-focused Recruiting nowThis study looks at whether DNA from blood, sputum, lung fluid, and breath can help find genetic changes in non-small cell lung cancer. Researchers will collect samples from 210 patients before and after surgery, then follow them for 24 months to check for cancer return. The goal…
Matched conditions: CIRCULATING TUMOR DNA
Sponsor: St. Joseph's Healthcare Hamilton • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Blood test could revolutionize cancer monitoring
Knowledge-focused Recruiting nowThis study is collecting blood samples from 1,000 people with digestive, gynecologic, or breast cancers to see if pieces of tumor DNA floating in the blood (called ctDNA) can help doctors diagnose cancer, predict how the disease will progress, and check if treatments are working.…
Matched conditions: CIRCULATING TUMOR DNA
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC